Table 1 Population characteristics (N(%) or median(IQR)).
From: Environmental noise exposure is associated with atherothrombotic risk
N (%) or Median (IQR) | Men (N = 567) | Women (N = 312) | Total (N = 879) |
|---|---|---|---|
Patient characteristics | |||
Age (years) | 64 (54–76) | 78 (67–85) | 70 (57–80) |
Age (classes)a | |||
< 75 | 404 (71.3%) | 121 (38.8%) | 525 (59.7%) |
≥ 75 | 163 (28.7%) | 191 (61.2%) | 354 (40.3%) |
BMI (kg/m2) | 26 (24–29) | 25 (22–29) | 26 (24–29) |
Obesity (BMI ≥ 30) | 82 (14.5%) | 48 (15.8%) | 130 (15.0%) |
Hypertensiona | 264 (46.6%) | 216 (69.2%) | 480 (54.6%) |
Diabetes mellitusa | 117 (20.6%) | 74 (23.7%) | 191 (21.7%) |
Hypercholesterolemia | 245 (43.5%) | 145 (46.9%) | 390 (44.7%) |
Current smokinga | 195 (34.4%) | 43 (13.8%) | 238 (27.1%) |
Socio-economic levelb | |||
Affluent | 149 (26.3%) | 70 (22.4%) | 219 (24.9%) |
Mixed | 348 (61.4%) | 211 (67.6%) | 559 (63.6%) |
Deprived | 70 (12.3%) | 31 (9.9%) | 101 (11.5%) |
Comorbidities | |||
Previous CAD | 36 (6.3%) | 29 (9.3%) | 65 (7.4%) |
Family history of CAD | 130 (23.4%) | 94 (30.9%) | 224 (26.1%) |
Prior strokea | 29 (5.1%) | 29 (9.3%) | 58 (6.6%) |
PADa | 46 (8.1%) | 22 (7.1%) | 68 (7.7%) |
Prior CABGa | 5 (0.9%) | 5 (1.6%) | 10 (1.1%) |
Congestive heart failurea | 23 (4.1%) | 11 (3.5%) | 34 (3.9%) |
COPD | 27 (4.8%) | 15 (4.8%) | 42 (4.8%) |
Renal failurea | 157 (27.7%) | 144 (46.2%) | 301 (34.2%) |
Clinical data | |||
Heart rate (beat/min)a | 78 (64–90) | 80 (68–96) | 79 (66–92) |
Systolic blood pressure (mmHg) | 140 (123–160) | 141 (124–165) | 140 (123–160) |
Diastolic blood pressure (mmHg) | 83 (71–95) | 80 (70–90) | 80 (70–93) |
LVEF (%) | 55 (46–65) | 54 (45–63) | 55 (45–65) |
LVEF ≤ 40% | 89 (17.7%) | 59 (21.1%) | 148 (18.9%) |
STEMI | 311 (54.9%) | 158 (50.6%) | 469 (53.4%) |
Anterior wall location | 186 (32.8%) | 127 (40.7%) | 313 (35.6%) |
Killip class on admission | |||
1 | 474 (83.6%) | 228 (74.0%) | 702 (80.2%) |
2 | 63 (11.1%) | 55 (17.9%) | 118 (13.5%) |
3 | 26 (4.6%) | 24 (7.8%) | 50 (5.7%) |
4 | 4 (0.7%) | 1 (0.3%) | 5 (0.6%) |
Chronic medications | |||
Aspirin | 69 (13.0%) | 51 (17.6%) | 120 (14.7%) |
Statin | 101 (19.1%) | 67 (23.1%) | 168 (20.5%) |
TRS-2P score | |||
Low risk | |||
0 | 82 (14.5%) | 25 (8.0%) | 107 (12.2%) |
1 | 200 (35.3%) | 52 (16.7%) | 252 (28.7%) |
Low medium risk | |||
2 | 144 (25.4%) | 82 (26.3%) | 226 (25.7%) |
High medium risk | |||
3 | 88 (15.5%) | 104 (33.3%) | 192 (21.8%) |
High risk | |||
4 | 32 (5.6%) | 33 (10.6%) | 65 (7.4%) |
5 | 15 (2.6%) | 13 (4.2%) | 28 (3.2%) |
6 | 4 (0.7%) | 3 (1.0%) | 7 (0.8%) |
7 | 2 (0.4%) | 0 (0.0%) | 2 (0.2%) |
